Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Cash & Equivalents (2021 - 2025)

Indivior Pharmaceuticals has reported Cash & Equivalents over the past 5 years, most recently at $195.0 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $195.0 million for Q4 2025, down 38.87% from a year ago — trailing twelve months through Dec 2025 was $195.0 million (down 38.87% YoY), and the annual figure for FY2025 was $195.0 million, down 38.87%.
  • Cash & Equivalents for Q4 2025 was $195.0 million at Indivior Pharmaceuticals, down from $445.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for INDV hit a ceiling of $1.1 billion in Q4 2021 and a floor of $195.0 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $408.5 million (2025), compared with a mean of $504.1 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 59.17% in 2023 and later grew 0.95% in 2024.
  • Indivior Pharmaceuticals' Cash & Equivalents stood at $1.1 billion in 2021, then fell by 29.76% to $774.0 million in 2022, then tumbled by 59.17% to $316.0 million in 2023, then increased by 0.95% to $319.0 million in 2024, then plummeted by 38.87% to $195.0 million in 2025.
  • The last three reported values for Cash & Equivalents were $195.0 million (Q4 2025), $445.0 million (Q3 2025), and $510.0 million (Q2 2025) per Business Quant data.